GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vivoryon Therapeutics VVY.AS · EUR

Health Care · Euronext Amsterdam · 🇳🇱 Netherlands

Compare

0.66

+6.15%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Vivoryon Therapeutics — daily VVY

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Vivoryon Therapeutics on TradingView ↗
Market value
€17.1m
Last close × shares
Volume
121.3k
Shares, 9 Nov 2026

About Vivoryon Therapeutics

Its shares trade on Euronext Amsterdam under the ticker VVY.AS. In the fiscal year to 31 December 2025, it reported a net loss of €8.9m. At that date it held total assets of €7.5m and shareholders' equity of €4.7m.

Vivoryon Therapeutics AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. The company is headquartered in Halle, Sachsen-Anhalt. The firm offers medicines that targets post-translational modifying enzymes. The company focuses on Alzheimer's disease and oncology.

Figures and description from our data supplier, not checked against the company's own report.

More about Vivoryon Therapeutics →

Latest on Vivoryon Therapeutics

Our reporting

We have not reported on Vivoryon Therapeutics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Vivoryon Therapeutics's ticker?

Vivoryon Therapeutics trades as VVY.AS on Euronext Amsterdam, under ISIN NL00150002Q7.

What was Vivoryon Therapeutics's last closing price?

0.66 on 9 Nov 2026. The figure is in EUR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.